Literature DB >> 19028278

Bystander effects induced by continuous low-dose-rate 125I seeds potentiate the killing action of irradiation on human lung cancer cells in vitro.

Hong H Chen1, Rong F Jia, Lei Yu, Mei J Zhao, Chun L Shao, Wen Y Cheng.   

Abstract

PURPOSE: To investigate bystander effects of low-dose-rate (LDR) (125)I seed irradiation on human lung cancer cells in vitro. METHODS AND MATERIALS: A549 and NCI-H446 cell lines of differing radiosensitivity were directly exposed to LDR (125)I seeds irradiation for 2 or 4 Gy and then cocultured with nonirradiated cells for 24 hours. Induction of micronucleus (MN), gammaH2AX foci, and apoptosis were assayed.
RESULTS: After 2 and 4 Gy irradiation, micronucleus formation rate (MFR) and apoptotic rate of A549 and NCI-H446 cells were increased, and the MFR and apoptotic rate of NCI-H446 cells was 2.1-2.8 times higher than that of A549 cells. After coculturing nonirradiated bystander cells with (125)I seed irradiated cells for 24 hours, MFR and the mean number of gammaH2AX foci/cells of bystander A549 and NCI-H446 cells were similar and significantly higher than those of control (p <0.05), although they did not increase with irradiation dose. However, the proportion of bystander NCI-H446 cells with MN numbers >/=3 and gammaH2AX foci numbers 15-19 and 20-24 was higher than that of bystander A549 cells. In addition, dimethyl sulfoxide (DMSO) treatment could completely suppress the bystander MN of NCI-H446 cells, but it suppressed only partly the bystander MN of A549 cells, indicating that reactive oxygen species are involved in the bystander response to NCI-H446 cells, but other signaling factors may contribute to the bystander response of A549 cells.
CONCLUSIONS: Continuous LDR irradiation of (125)I seeds could induce bystander effects, which potentiate the killing action on tumor cells and compensate for the influence of nonuniform distribution of radiation dosage on therapeutic outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028278     DOI: 10.1016/j.ijrobp.2008.07.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells.

Authors:  M He; M Zhao; B Shen; K M Prise; C Shao
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

Review 2.  Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer.

Authors:  Kecheng Xu; Lizhi Niu; Feng Mu; Yize Hu
Journal:  Gland Surg       Date:  2013-05

3.  Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer.

Authors:  Wang Zhongmin; Liu Yu; Liu Fenju; Chen Kemin; Huang Gang
Journal:  Eur Radiol       Date:  2010-01-13       Impact factor: 5.315

4.  Effectiveness and security of CT-guided percutaneous implantation of (125)I seeds in pancreatic carcinoma.

Authors:  Y-P Yu; Q Yu; J-M Guo; H-T Jiang; X-Y Di; Y Zhu
Journal:  Br J Radiol       Date:  2014-04-15       Impact factor: 3.039

5.  Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma.

Authors:  Zhongmin Wang; Jian Lu; Lin Liu; Tao Liu; Kemin Chen; Fenju Liu; Gang Huang
Journal:  Radiat Oncol       Date:  2011-10-18       Impact factor: 3.481

6.  Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors.

Authors:  Liyun Zhang; Jian Lu; Zhongmin Wang; Yingsheng Cheng; Gaojun Teng; Kemin Chen
Journal:  Onco Targets Ther       Date:  2015-12-18       Impact factor: 4.147

7.  Continuous Low-dose-rate Irradiation of Iodine-125 Seeds Inhibiting Perineural Invasion in Pancreatic Cancer.

Authors:  Zheng Lu; Teng-Hui Dong; Pei-Ren Si; Wei Shen; Yi-Liang Bi; Min Min; Xin Chen; Yan Liu
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

8.  Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.

Authors:  Xiaojuan Yu; Jin Li; Xiaoming Zhong; Jingdong He
Journal:  BMC Cancer       Date:  2015-10-06       Impact factor: 4.430

9.  Efficacy and safety of percutaneous microwave coagulation therapy followed by 125I seed brachytherapy for VX2 hepatic tumors in a rabbit model.

Authors:  Dong-Sheng Yu; Hong Chang; Christof-Matthias Sommer; Wei-Li Qu; Wen-Jian Xu; Ren-Jie Yang; Peng Zhao
Journal:  Exp Ther Med       Date:  2013-04-29       Impact factor: 2.447

10.  Reactive oxygen species formation and bystander effects in gradient irradiation on human breast cancer cells.

Authors:  Dongqing Zhang; Tingyang Zhou; Feng He; Yi Rong; Shin Hee Lee; Shiyong Wu; Li Zuo
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.